Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,016 public trials 2,026 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • New York Medical College Valhalla, New York, United States
  • Carolinas Medical Center/ Levine Children's Hospital Charlotte, North Carolina, United States
  • Levine Children's Health Charlotte, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

NCT07630545

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations
  • The Royal Adelaide Hospital Adelaide, Australia
  • Doherty Clinical Trials Melbourne, Australia
  • Monash Health, Kingston Centre Melbourne, Australia
  • Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon Lille, France
View all 18 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06973187

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Kaiser Permanente Southern California Irvine, California, United States
  • University of California San Diego (Ucsd) Moores Cancer Center La Jolla, California, United States
View all 197 locations
View Trial Details
Recruiting

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06634589

Conditions
B-cell Lymphoma, B-cell Malignancy, Disease Attributes, +15 more
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • University of Southern California Norris Comprehensive Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 50 locations
View Trial Details
Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions
Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Hopital Robert Debre Paris, France
  • Armand Trousseau Hospital Paris, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View all 23 locations
View Trial Details

Related conditions